S. R. Friedman

D. D. Des Jarlais, A. Neaigus, S. Friedman, 1990, AIDS education and prevention : official publication of the International Society for AIDS Education.

S. Vermund, R. Curtis, A. Neaigus, 2000, American journal of epidemiology.

Fifteen years of research on preventing HIV infection among injecting drug users: what we have learned, what we have not learned, what we have done, what we have not done.

D. D. Des Jarlais, S. Friedman, D. C. Jarlais, 1998, Public health reports.

Maintaining low HIV seroprevalence in populations of injecting drug users.

D. D. Des Jarlais, H. Hagan, M. Frischer, 1995, JAMA.

Risk factors for HIV-1 seroprevalence among drug injectors in the cocaine-using environment of Rio de Janeiro.

D. D. Des Jarlais, F. Bastos, S. Friedman, 1994, Addiction.

Crack cocaine use in a cohort of methadone maintenance patients.

D. D. Des Jarlais, M. Marmor, J. Wenston, 1992, Journal of substance abuse treatment.

Social intervention against AIDS among injecting drug users.

A. Neaigus, C. Sterk, B. Stepherson, 1992, British journal of addiction.

AIDS and the new drug injector

A. Abdul-Quader, S. Tross, A. Neaigus, 1989, Nature.

Intravenous drug use and the heterosexual transmission of the human immunodeficiency virus. Current trends in New York City.

D. D. Des Jarlais, W. El-Sadr, E. Wish, 1987, New York state journal of medicine.

Interventions for injecting drug users.

A. Abdul-Quader, D. D. Des Jarlais, S. Friedman, 2002 .

Laws prohibiting over-the-counter syringe sales to injection drug users: relations to population density, HIV prevalence, and HIV incidence.

S. Friedman, T. Perlis, D. C. Jarlais, 2001, American journal of public health.

Risk behavior and HIV infection among new drug injectors in the era of AIDS in New York City.

D. D. Des Jarlais, A. Neaigus, E. Monterroso, 1999, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

Risk reduction for the acquired immunodeficiency syndrome among intravenous drug users.

S. Friedman, D. C. Jarlais, W. Hopkins, 1985, Annals of internal medicine.

AIDS and the transition to illicit drug injection--results of a randomized trial prevention program.

D. D. Des Jarlais, A. Rosenblum, S. Friedman, 1992, British journal of addiction.

The global spread of HIV-1 subtype B epidemic

M. Poljak, A. Wensing, R. Paredes, 2016 .

Will the Russian war in Ukraine unleash larger epidemics of HIV, TB and associated conditions and diseases in Ukraine?

T. Vasylyeva, P. Smyrnov, S. R. Friedman, 2023, Harm Reduction Journal.

Estimates of injecting drug users at the national and local level in developing and transitional countries, and gender and age distribution

S. Friedman, M. Hickman, H. Cooper, 2006, Sexually Transmitted Infections.

Nonrandom development of immunologic abnormalities after infection with human immunodeficiency virus: implications for immunologic classification of the disease.

S. Zolla-Pazner, W. El-Sadr, S. Friedman, 1987, Proceedings of the National Academy of Sciences of the United States of America.

Sexual Problems: Diagnosis and Treatment in Medical Practice

S. Friedman, S. R. Friedman, 1967 .

Prevalence of antibody to lymphadenopathy-associated virus among drug-detoxification patients in New York.

S. Friedman, S. Yancovitz, T. Spira, 1984, The New England journal of medicine.

Factors associated with prevalent hepatitis C: differences among young adult injection drug users in lower and upper Manhattan, New York City.

D. Vlahov, D. Hoover, S. Friedman, 2001, American journal of public health.

Implications of directly observed therapy in tuberculosis control measures among IDUs.

R. Curtis, A. Neaigus, B. Jose, 1994, Public health reports.

AIDS and the social relations of intravenous drug users.

A. Abdul-Quader, S. Tross, C. Sterk, 1990, The Milbank quarterly.

The epidemic of acquired immunodeficiency syndrome (AIDS) and suggestions for its control in drug abusers.

W. El-Sadr, M. Marmor, D. C. Jarlais, 1984, Journal of substance abuse treatment.

Prevalence and correlates of anal sex with men among young adult women in an inner city minority neighborhood.

J. Zenilman, R. Curtis, M. Sandoval, 2001, AIDS.

Risk factors and HIV seropositivity among injecting drug users in Bangkok.

D. D. Des Jarlais, S. Friedman, M. Carballo, 1991, AIDS.

Sexual and other noninjection risks for HBV and HCV seroconversions among noninjecting heroin users.

D. D. Des Jarlais, Maureen Miller, S. Friedman, 2007, The Journal of infectious diseases.

HIV-1 infection among intravenous drug users in Manhattan, New York City, from 1977 through 1987.

Samuel R. Friedman, Don C. Des Jarlais, S. Friedman, 1989, JAMA.

HIV infection among intravenous drug users: epidemiology and risk reduction.

S. Friedman, D. C. Jarlais, D. Des Jarlais, 1987, AIDS.

Specificity of antibody tests for human immunodeficiency virus in alcohol and parenteral drug abusers with chronic liver disease.

S. Friedman, M. Kreek, T. Spira, 1988, Alcoholism, clinical and experimental research.

HIV infection among persons who inject illicit drugs: problems and prospects.

S. Friedman, D C Des Jarlais, S R Friedman, 1988, Journal of acquired immune deficiency syndromes.

Reduced risk of hepatitis B and hepatitis C among injection drug users in the Tacoma syringe exchange program.

M. Alter, H. Hagan, S. Friedman, 1995, American journal of public health.

Do metropolitan HIV epidemic histories and programs for people who inject drugs and men who have sex with men predict AIDS incidence and mortality among heterosexuals?

B. Tempalski, Cory M. Morton, H. Cooper, 2014, Annals of epidemiology.

The relevance of drug injectors' social and risk networks for understanding and preventing HIV infection.

R. Curtis, A. Neaigus, B. Jose, 1994, Social science & medicine.

STI/HIV Sexual Risk Behavior and Prevalent STI Among Incarcerated African American Men in Committed Partnerships: The Significance of Poverty, Mood Disorders, and Substance Use

A. Adimora, C. Golin, S. Friedman, 2015, AIDS and Behavior.

Contextual Predictors of Injection Drug Use Among Black Adolescents and Adults in US Metropolitan Areas, 1993-2007.

S. Friedman, B. Tempalski, H. Cooper, 2016, American journal of public health.

Evidence for action: effectiveness of community-based outreach in preventing HIV / AIDS among injecting drug users.

R. Needle, J. Dorabjee, G. Touzé, 2004 .

Declining seroprevalence in a very large HIV epidemic: injecting drug users in New York City, 1991 to 1996.

M Beardsley, D. D. Des Jarlais, L. Torian, 1998, American journal of public health.

Relative prevalence of different sexually transmitted infections in HIV-discordant sexual partnerships: data from a risk network study in a high-risk New York neighbourhood

J. Zenilman, S. Friedman, P. Mateu-Gelabert, 2007, Sexually Transmitted Infections.

Risk correlates of prevalent HIV, hepatitis B virus, and hepatitis C virus infections among noninjecting heroin users.

D. D. Des Jarlais, Maureen Miller, S. Friedman, 2002, Journal of acquired immune deficiency syndromes.

Working with heroin sniffers: clinical issues in preventing drug injection.

S. Friedman, D. D. des Jarlais, B. Stepherson, 1990, Journal of substance abuse treatment.

Gender differences in injection risk behaviors at the first injection episode.

Maureen Miller, S. Friedman, A. Neaigus, 2007, Drug and alcohol dependence.

Using dyadic data for a network analysis of HIV infection and risk behaviors among injecting drug users.

R. Curtis, A. Neaigus, B. Jose, 1995, NIDA research monograph.

S. Friedman, D. D. des Jarlais, R. Rockwell, 1999, Journal of acquired immune deficiency syndromes.

High-risk personal networks and syringe sharing as risk factors for HIV infection among new drug injectors.

R. Curtis, A. Neaigus, B. Jose, 1996, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

Potential risk factors for the transition to injecting among non-injecting heroin users: a comparison of former injectors and never injectors.

S. Sifaneck, A. Neaigus, G. Ildefonso, 2001, Addiction.

CD4 lymphocytopenia among injecting drug users in New York City.

S. Yancovitz, D. Mildvan, M. Marmor, 1993, Journal of acquired immune deficiency syndromes.